Are bioequivalence (BE) assessments of clinical significance and relevance? Not really!

A discussion is provided showing weakness of BE assessments for comparing or establishing quality of products such as tablet/capsule. It is argued that in vitro drug dissolution/release testing would provide a better alternative for the assessment of the quality of such pharmaceutical products. Please click here for complete article.

Comments are closed.

Crescent-Shaped Spindle

Now Available
Click here